5 Biotech Stocks We Like In 2026. And 5 We Dont. Anticiclone Africano [hx0ENMe8pRd]

Our disruptive technology investing methodology is an excellent way to help investors avoid garbage companies. Today, we'll talk about five biotech stocks we correctly called out as rubbish: Vicarious Surgical $RBOT, Bionano Genomics $BNGO, Renalytix $RNLXY, Lantern Pharma $LTRN, and CollPlant $CLGN, and five biotechs we like: Intuitive Surgical $ISRG, Tempus AI $TEM, TransMedics $TMDX, Recursion $RXRX, and United Therapeutics $UTHR.

RESEARCH PIECES USED IN THIS VIDEO:

1. Guide to Biotech Investing

2. Tempus Uses AI and Big Data for Precision Medicine

CHAPTERS:

00:00 Intro

00:41 Vicarious Surgical stock

02:10 Intuitive magasin liquidation marie granby Surgical stock

02:59 Bionano Genomics stock

05:09 Tempus AI autoroute 20 stock

06:28 Renalytix stock

08:37 TransMedics stock

09:08 Lantern Pharma stock

11:51 Recursion Pharmaceuticals stock

12:59 weather tomorrow CollPlant stock

14:23 United Therapeutics stock

15:35 Lessons

16:43 Conclusion

ABOUT US:

This video is brought to you by Nanalyze, a media and research firm founded by finance professionals with decades of experience. We share insights about #DisruptiveTechnology #stocks in a language that is future-proof and easy to understand.

Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30-day trial of our monthly subscription with no strings attached:

DISCLAIMER: Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, along with independently researching and verifying, any information contained within our YouTube videos or on our website, whether for the purpose of making an investment or otherwise.

#biotechnology

#biotechinvesting

#biotech